Analytical Data
-
Gene name
POTEKP
- Application
-
Alternative Names
POTEKP；ACTBL3；Putative beta-actin-like Protein 3
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BYX7
-
Expression Region
1-375aa
-
AA Sequence
MDDDTAVLVIDNGSGMCKAGFAGDDAPQAVFPSIVGRPRHQGMMEGMHQKESYVGKEAQSKRGMLTLKYPMEHGIITNWDDMEKIWHHTFYNELRVAPEEHPILLTEAPLNPKANREKMTQIMFETFNTPAMYVAIQAVLSLYTSGRTTGIVMDSGDGFTHTVPIYEGNALPHATLRLDLAGRELTDYLMKILTERGYRFTTTAEQEIVRDIKEKLCYVALDSEQEMAMAASSSSVEKSYELPDGQVITIGNERFRCPEALFQPCFLGMESCGIHKTTFNSIVKSDVDIRKDLYTNTVLSGGTTMYPGIAHRMQKEITALAPSIMKIKIIAPPKRKYSVWVGGSILASLSTFQQMWISKQEYDESGPSIVHRKCF
-
Molecular Weight
49.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
POTEKP is a member of the POTE family of genes, which are known for their involvement in tumorigenesis and immune response modulation. The study of POTEKP has gained traction due to its unique expression patterns in various cancers, particularly in prostate and breast cancer, where it has been associated with disease progression and poor prognosis. Unlike other members of the POTE family, POTEKP is characterized by a distinct structural motif, which may contribute to its functional diversity in cellular processes. Recent research efforts have focused on understanding its role in oncogenic signaling pathways and its potential as a biomarker for cancer diagnosis and prognosis. Moreover, the unique properties of POTEKP make it an interesting target for therapeutic intervention, potentially leading to the development of novel cancer treatments. As the field of cancer research explores the molecular underpinnings of tumorigenesis, POTEKP presents a promising avenue for further investigation, offering insights into the intricate relationship between gene expression and cancer biology.
